Episodes
Medicare Drug Pricing in DC
Congress may soon revisit legislation to tackle the high costs of prescription drugs under Medicare. But drug pricing is never a …
When Might You Get the COVID-19 Shot?
Vaccine distribution is off to a rocky start. While some states are exceeding expectations, others continue to lag behind. This w…
Mystery Hospital Costs
With the new Hospital Price Transparency rule, patients will finally be able to view and compare the costs of services across hos…
Will Democrats Help or Hurt Patients?
Democrats soon will control Congress and the White House. What should patients with chronic conditions expect from a federal gove…
Pro-Patient Agenda Revealed
Congress and the new Biden White House are ready to hit the ground running in 2021. So we’re here to make sure patient needs are …
Patients Hurt by Most Favored Nation Rule
The Most Favored Nation Rule will take effect on January 1st. It’s bad news for Medicare infusion patients and providers, but the…
Navigating Legal Hurdles
Navigating the legal issues that come with a cancer diagnosis is challenging. From employer discrimination to financial toxicity,…
What Will Biden Do for Patients?
As President-elect Joe Biden makes his health team picks, we discuss what patients may expect out of a new Democratic Administrat…
Can Politicians Work Together for You?
Can Republicans and Democrats work together to help the chronic disease community? Former FDA Commissioner Dr. Mark McClellan pre…
Fighting Pancreatic Cancer
In the wake of Alex Trebek’s passing, we take a look at the state of pancreatic cancer treatments and care. Julie Fleshman, CEO o…
How Precision Medicine Can Help You
Precision medicine is revolutionizing cancer care. Dr. Razelle Kurzrock highlights how personalized treatments improve patient ou…
Patient Victory for Price Transparency
Power to patients! A new price transparency rule from the U.S. Department of Health and Human Services will allow you to see exac…
How PBMs Profit at Your Expense
As a heated election season wraps up, Terry and Dr. Bob examine the latest results and what they mean for patients and federal he…
Your Access to Gene Therapies
Gene therapies can be lifesaving for many patients. But accessing them can be a challenge of its own. Terry and Dr. Bob discuss t…
Vaccine Misinformation
States have begun to release their vaccine distribution plans, and President Trump and Biden spent the final debate sparring over…
Improving Drug Safety
Drug pricing continues to make the news, so we’re revisiting our conversation with Dr. Janet Woodcock of the FDA about bringing d…
Can You Get Trump’s COVID Care?
President Trump’s apparent quick and successful battle with the COVID-19 virus should set the standard for care that all American…
RBG Spot + Healthcare’s Future
The future of the Affordable Care Act is uncertain with a Supreme Court vacancy. Terry and Dr. Bob discuss protections for preexi…
2020: Year of the Patient
Cancer research may yield a potential COVID-19 therapeutic. Dr. Bob interviews Dr. John Rothman of Tyme Technologies about the pr…
The Vaccine Finish Line
The finish line for the vaccine race is just around the corner. Terry and Dr. Bob react to vaccine developments and respond to IC…
What Goes Into Drug Prices
Get an inside look into the drug supply chain and the factors that impact your bill at the pharmacy counter. Dr. Robert Popovian,…
Chronic Disease in the Workplace
In celebration of Labor Day, we look at a business that is empowering the chronic disease community. Kate interviews Keisha Greav…
Finding Cures Faster
The lives of chronic and rare disease patients depend on the progress of medical discoveries. Dr. Gary Michelson explains how inv…
Calculating the Value of Patient Lives
ICER’s pricing models assess the value of a drug and whether your life is worth paying for it. Health economist Dr. Paul Langley …